FACT Expresses Deep Appreciation to Outgoing Board Members
Wisdom, intelligence, dedication, and kindness are words that describe all the outgoing members of the FACT Board of Directors, who were recently recognized with service awards. These servant leaders maintained a steady presence in FACT’s early years, steered the organization into new developments in cellular therapies, and guided us through challenges such as the pandemic. They are street-smart visionaries who viewed the future with measured confidence. We genuinely thank these individuals for setting FACT up for success for years to come.
Paul Eldridge, PhD
- FACT Board of Directors: 2014 – 2021
- Chair, Standards Development Committee: 2016–2021; Member 2014 – Present
- Member, Cell Therapy Accreditation Committee 2017–Present
- Member, Cord Blood Bank Accreditation Committee 2017–Present
- FACT Representative: WBMT
- FACT Inspector for 21 years; performed 27 inspections
Joseph Schwartz, MD, MBA
- FACT Board of Directors: 2013 – 2021
- Chair, Technology Committee: 2020 – Present
- Chair, Standards Development Committee: 2013–2015, Member 2010-Present
- Member, Cell Therapy Accreditation Committee 2012–Present
- Member, Cord Blood Bank Accreditation Committee 2013–Present
- Chair, HLA Typing Committee: 2017
- Member, Education Committee: 2015-Present
- Professional Relations Committee: 2014-2019
- FACT Representative: AHCTA
- FACT Inspector for 15 years; performed 36 inspections
Dennis Gastineau, MD
- FACT Board of Directors
- Past President: 2021
- President: 2016-2020
- President-Elect: 2014-2015
- Vice President: 2010-2013
- Secretary: 2009
- Board Member: 2005-2008
- Inaugural Chair Education Committee: 2007–2013, Member 2014-2021
- Member, Clinical Outcomes Improvement Committee: 2015-2022
- Member, Leadership & Nominations Committee: 2010–2021
- Member Finance Committee: 2009
- Member, Cell Therapy Accreditation Committee: 2007-2021
- FACT Inspector for 20 years; performed 31 inspections
